Page last updated: 2024-09-04

atrasentan and oblimersen

atrasentan has been researched along with oblimersen in 2 studies

Compound Research Comparison

Studies
(atrasentan)
Trials
(atrasentan)
Recent Studies (post-2010)
(atrasentan)
Studies
(oblimersen)
Trials
(oblimersen)
Recent Studies (post-2010) (oblimersen)
358411081954027

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, W1
Becker, M; Börgermann, C; Hess, J; Rübben, H; Schenck, M; Vom Dorp, F1

Reviews

1 review(s) available for atrasentan and oblimersen

ArticleYear
[Promising new treatment options for metastatic androgen-independent prostate cancer].
    Actas urologicas espanolas, 2007, Volume: 31, Issue:6

    Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Benzamides; Benzenesulfonates; Bevacizumab; Calcitriol; Cancer Vaccines; Docetaxel; Drug Screening Assays, Antitumor; Epothilones; Forecasting; Humans; Imatinib Mesylate; Male; Niacinamide; Phenylurea Compounds; Piperazines; Prostatic Neoplasms; Pyridines; Pyrimidines; Pyrrolidines; Randomized Controlled Trials as Topic; Salvage Therapy; Sorafenib; Taxoids; Thionucleotides

2007

Other Studies

1 other study(ies) available for atrasentan and oblimersen

ArticleYear
[Value of targeted therapy for prostate cancer].
    Der Urologe. Ausg. A, 2008, Volume: 47, Issue:10

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Atrasentan; Calcitriol; Drug Delivery Systems; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Protein-Tyrosine Kinases; Pyrrolidines; Sirolimus; Survival Rate; Thionucleotides

2008